Read the 10K most of the sections are clearly NOT boilerplate. They have repeatedly covered issues with their clinical trials -- clearly NOT boilerplate. As clearly proper due diligence needs to be done, would suggest actually reading the Risks would make sense.
Market Data 
Markets 
AI
